Invention Grant
- Patent Title: STAT3 inhibitors and their anticancer use
-
Application No.: US14421776Application Date: 2013-08-16
-
Publication No.: US09783513B2Publication Date: 2017-10-10
- Inventor: Chenglong Li , Wenying Yu , Jiayuh Lin
- Applicant: Ohio State Innovation Foundation , Research Institute at Nationwide Children's Hospital
- Applicant Address: US OH Columbus US OH Columbus
- Assignee: Ohio State Innovation Foundation,Research Institute at Nationwide Children's Hospital
- Current Assignee: Ohio State Innovation Foundation,Research Institute at Nationwide Children's Hospital
- Current Assignee Address: US OH Columbus US OH Columbus
- Agency: Foley & Lardner LLP
- Agent Antoinette F. Konski; Lydia B. Choi
- International Application: PCT/US2013/055474 WO 20130816
- International Announcement: WO2014/028909 WO 20140220
- Main IPC: C07C50/12
- IPC: C07C50/12 ; C07D275/06 ; C07D213/74 ; C07C307/02 ; C07D233/54 ; C07D211/26 ; C07D295/135 ; C07D401/04 ; C07D405/04 ; C07D409/04

Abstract:
In one aspect, the invention relates to substituted 6-amino-5,8-dioxo-5,8-dihydronaphthalene-1-sulfonamide analogs and derivatives thereof, substituted 4-amino-5H-naphtho[1,8-cd]isothiazol-5-one 1,1-dioxide analogs and derivatives thereof, and related compounds, which are useful as inhibitors of STAT protein activity; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders of uncontrolled cellular proliferation associated with a STAT protein activity dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Public/Granted literature
- US20150232434A1 STAT3 INHIBITORS AND THEIR ANTICANCER USE Public/Granted day:2015-08-20
Information query